首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Antiviral Activity of Total Flavonoid Extracts fromSelaginella moellendorffiiHieron against Coxsackie Virus B3In VitroandIn Vivo
【24h】

Antiviral Activity of Total Flavonoid Extracts fromSelaginella moellendorffiiHieron against Coxsackie Virus B3In VitroandIn Vivo

机译:产卷柏总黄酮提取物对体外和体内柯萨奇病毒B3的抗病毒活性

获取原文
       

摘要

The antiviral activity of total flavonoid extracts fromSelaginella moellendorffiiHieron and its main constituents amentoflavone were investigated against coxsackie virus B3 (CVB3). When added during or after viral infection, the extracts and amentoflavone prevented the cytopathic effect (CPE) of CVB3, as demonstrated in a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) colorimetric assay, with a 50% inhibitory concentration (IC50) from19±1.6to41±1.2 μg/mL and25±1.2to52±0.8 μg/mL, respectively. KM mice were used as animal models to test the extracts' activityin vivo. Oral administration of the total flavonoid extracts at 300 mg/kg/day significantly reduced mean viral titers in the heart and kidneys as well as mortality after infection for 15 days. The experimental results demonstrate thatin vitroandin vivothe model mice infected with CVB3 can be effectively treated by the total flavonoid extracts fromSelaginella moellendorffiiHieron.
机译:研究了卷柏(Selaginella moellendorffiiHieron)总黄酮提取物及其主要成分金黄色素(Amentoflavone)对柯萨奇病毒B3(CVB3)的抗病毒活性。当在病毒感染期间或之后加入时,提取物和黄酮能阻止CVB3的细胞病​​变作用(CPE),如3-(4,5-二甲基噻唑-2-基)-2,5-二苯基溴化四氮唑(MTT)所示比色法,抑制浓度(IC50)分别为19±1.6至41±1.2μg/ mL和25±1.2至52±0.8μg/ mL。 KM小鼠被用作动物模型以测试提取物的体内活性。口服总黄酮提取物的剂量为300μmg/ kg /天,可显着降低心脏和肾脏的平均病毒滴度以及感染15天后的死亡率。实验结果表明,可以用总生黄柏中总黄酮提取物有效治疗CVB3感染的模型小鼠。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号